Giovangiacinto Paterno

9PUBLICATIONS
70CO-AUTHORS
NanomedicineMedical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Jan 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.

Elisa Buzzatti, Cristina Mauro, Cristiano Tesei

|Jun 26, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.

Elisa Buzzatti, Giovangiacinto Paterno, Raffaele Palmieri

|Feb 26, 2025
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response.

Valeria Mezzanotte, Giovangiacinto Paterno, Ilaria Cerroni

|Nov 26, 2022
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience.

Giovangiacinto Paterno, Raffaele Palmieri, Vittorio Forte

|Sep 05, 2022
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.

Maria Ilaria Del Principe, Danila Seidel, Marianna Criscuolo

Pageof 2

Frequent Collaborators

7 joint publications

Francesco Buccisano

7 joint publications

Adriano Venditti

6 joint publications

Raffaele Palmieri

6 joint publications

Luca Maurillo